Divergent position on a CVMP opinion on the establishment of maximum residue limits For extension of fluazuron for fin fish (automatic extrapolation to milk)

Procedure no: EMEA/V/MRL/003471/EXTN/0002 We, the undersigned, have a divergent position to the outcome of the extrapolation and establishment of an MRL for fluazuron for milk. The Regulation 2017/880, which establishes minimum criteria for derivation of MRLs between species and foodstuffs, does not exclude the need for decisions based on a sufficiently comprehensive and relevant set of data. Going through the article 7 of this regulation, point (e) states that consideration of the physicochemical characteristics of the active substance and possible accumulation in milk should be given. Reading summary reports and the assessment report that was prepared for the current procedure, the following can be summarised: •

We do not have accessible any relevant scientific information concerning the behaviour

and fate of fluazuron in milk, nor are literature sources of information on residues depletion data in milk available. •

No data concerning the depletion of the substance from milk have ever been submitted

over the years and there is no evidence to indicate that there is any intention to submit such data. •

The CVMP has estimated the safe level based on a mathematic calculation only (even if the

conclusion is that exposure does not represent a sizable part of the ADI). The approach of establishing an MRL value without any appropriate data and waiting to see what will happen in future is unacceptable for safety of food production. From our point of view, no appropriate data are available for relevant risk assessment and successful risk management. A full data package needs to be submitted in order to allow establishment of a MRL for milk. Furthermore, unavailability of fluazuron for the treatment of dairy cattle does not represent an availability problem as there is a range of available medicines for treatment of dairy cattle. For the purpose of managing possible residues from third countries then we can use the draft Commission implementing regulation on the maximum residue limits to be considered for control purposes for foodstuffs derived from animals which have been treated under Article 11 of Directive 2001/82/EC. In such a case, the value of 200 µg/kg should be applicable and be used. Leona Nepejchalová Gábor Kulcsár

London, 5 October 2017

1

Divergent position on a CVMP opinion on the establishment of ...

Reading summary reports and the assessment report that was prepared for the current procedure, the following can be summarised: •. We do not have accessible any relevant scientific information concerning the behaviour and fate of fluazuron in milk, nor are literature sources of information on residues depletion data in.

25KB Sizes 0 Downloads 319 Views

Recommend Documents

Divergent position on a CVMP opinion on the establishment of ...
The CVMP has estimated the safe level based on a mathematic calculation only (even if the conclusion is that exposure does not represent a sizable part of the ...

Alarelin - Summary opinion of the CVMP on the establishment of ...
On 12 April 2017, the Committee for Medicinal Products for Veterinary Use (CVMP) adopted an opinion2 recommending the inclusion of alarelin in all food ...

Diflubenzuron - Summary opinion of the CVMP on the establishment ...
Mar 15, 2018 - 30 Churchill Place ○ Canary Wharf ○ London E14 5EU ○ United Kingdom. An agency of the European Union ... Animal species. MRLs. Target tissues. Other provisions. Therapeutic classification. Diflubenzuron Diflubenzuron. Salmonidae.

Divergent position on the establishment of MRLs for fluazuron
Going through the article 7 of this regulation, point (e) states that consideration ... establishing an MRL value without any appropriate data and waiting to see ...

CVMP opinion on fluazuron - European Medicines Agency - Europa EU
Oct 5, 2017 - Veterinary Use on the establishment of maximum residue limits. Procedure no: EMEA/V/MRL/003471/EXTN/0002. Name of the substance: ...

Solvent naphtha, light aromatic - Summary opinion of the CVMP on the ...
Oct 6, 2017 - 30 Churchill Place ○ Canary Wharf ○ London E14 5EU ○ United Kingdom. An agency of the European Union. Telephone ... Animal species. MRLs. Target tissues. Other provisions. Therapeutic classification. Solvent naphtha, light aromati

Implementation of CVMP guideline on environmental impact ...
18 Jan 2018 - 30 Churchill Place ○ Canary Wharf ○ London E14 5EU ○ United Kingdom. An agency of the European Union. Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555. Send a question via our website www.ema.europa.eu/contact. © Europ

opinion on privatization of slaughterhouse.pdf
trade or business establishment[s] as legitimate exercise of their corporate. and/or proprietary power[s]. I. FACTUAL BACKGROUND. The City Government of ...

Opinion of the HMPC on a European Union herbal monograph on ...
Send a question via our website www.ema.europa.eu/contact ... The HMPC, in accordance with Article 16h(3) of Directive 2001/83/EC, as amended, and as set ...

Opinion of the HMPC on a European Union herbal monograph on ...
An agency of the European Union. Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555. Send a question via our website www.ema.europa.eu/ ...

Procedural advice on re-examination of CVMP opinions - European ...
Nov 9, 2017 - be based only on the scientific data available when the Committee ... Article 34(1) and (2) of Regulation (EC) No 726/2004 shall apply to the ...

The Effect of Banks' Financial Position on Credit ...
li,tb. 2. 0.504. 0.285. 0.678. 0.577. 0.544. 0.693. 0.601. 0.578 σ2 µi/σ. 2 vit. 0.219. H. 0 .... CAP i,tb. 1. OLS. FE diff erence. GMM system. GMM. 2 collapsed. 4.

PrRe_EPSA Statement of Opinion on Self-Care.pdf
Whoops! There was a problem loading more pages. Retrying... Whoops! There was a problem previewing this document. Retrying... Download. Connect more apps... Try one of the apps below to open or edit this item. PrRe_EPSA Statement of Opinion on Self-C

9th-Circuit-s-opinion-on-the-muslim-ban.pdf
MINNESOTA, ... Before: William C. Canby, Richard R. Clifton, and. Michelle T. Friedland .... Main menu. Displaying 9th-Circuit-s-opinion-on-the-muslim-ban.pdf.

Comments on Water Resource Management Position Paper.pdf ...
Comments on Water Resource Management Position Paper.pdf. Comments on Water Resource Management Position Paper.pdf. Open. Extract. Open with.

Scientific Opinion on the substantiation of a health claim ... - DTU Orbit
Community list of permitted claims referred to in Article 13(3). .... borborygmi/rumbling stomach, bloating, flatulence, constipation, diarrhoea, abdominal pain and.

Position Statement on Conscientious Objection - Australian Medical ...
AMA Position Statement. Australian Medical ... 5. When a doctor refuses to provide, or participate in, a medically appropriate treatment or procedure based on a ...

A postdoctoral position is available on an NSF-funded project ...
each species, and (2) analyzing observed animal movement patterns to evaluate what ... animal capture, GPS-tracking and GIS software are highly desirable.

Scientific Opinion on the substantiation of a health claim related to ...
... consumes 20 % of the energy provided by the diet. Glucose is ingested in form of monosaccharides or in form of di- oligo- and polysaccharides, mainly starch,.

Position Paper on Contractualization.pdf
Thanks to the sunshine industry of BPO and the work. opportunities that abound for Filipinos abroad, the ill-effects of an untenable unemployment rate is ...

A postdoctoral position is available on an NSF-funded project ...
each species, and (2) analyzing observed animal movement patterns to ... work and data collection to managing and analyzing data to writing manuscripts and.

CVMP opinion for solvent naphtha, light aromatic - European ...
Oct 5, 2017 - Pursuant to Article 3 of Regulation (EC) No 470/2009 of 6 May 2009, Zoetis Belgium SA submitted to the. European Medicines Agency on 2 ...